Product/Composition:- | Spironolactone tablets |
---|---|
Strength:- | 25 mg, 50 mg, 100 mg |
Form:- | Tablet |
Reference Brands:- | Aldactone(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Spironolactone is a potassium-sparing diuretic that blocks aldosterone receptors, reducing sodium and water retention while conserving potassium. It effectively treats heart failure, hypertension, and hormonal conditions like acne. Benefits include lowering blood pressure, reducing edema, improving cardiac function, and supporting hormone balance, enhancing overall cardiovascular and hormonal health.
Spironolactone tablets, marketed as Aldactone, are approved in the US by the FDA and in the EU via EMA for conditions like edema, hypertension, and hyperaldosteronism. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed trial and quality data, while the EMA ensures compliance with safety and manufacturing standards across Europe. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and broader global availability of spironolactone tablets, helping manage cardiovascular and hormonal health effectively worldwide